CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Planned sale CEO sold 1,983,257 shares at $11.79 ($23,382,600)
- 4 Planned sale Chief Accounting Officer sold 250,000 shares at $11.89 ($2,972,500)
- 4 Shares withheld for taxes CFO gave up 2,129 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
- 4 Other disposition Director disposed of 3,487 shares (other)
- 4 Other disposition Director disposed of 3,056 shares (other)
- 4 Other disposition Director disposed of 4,245 shares (other)
- 4 Other disposition Director disposed of 2,599 shares (other)
- 4 Other disposition Director disposed of 894 shares (other)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Grant or award Director acquired 16,406 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 10,947 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,947 shares (to pay taxes)
- 4 Grant or award CEO acquired 17,204,821 shares (grant or award)
Page 11 of 26 · 511 filings